Open AccessTenofovir-associated renal dysfunction in clinical practice: An observational cohort from western India
Author(s) -
Ketan Patel,
Atul Patel,
Ravi Ranjan,
Apurva R. Patel,
Jagdish K. Patel
Publication year - 2010
Publication title -
indian journal of sexually transmitted diseases
Language(s) - English
Resource type - Journals
eISSN - 1998-3816
pISSN - 0253-7184
DOI - 10.4103/0253-7184.68998
Subject(s) - medicine , creatinine , renal function , regimen , fanconi syndrome , urology , cohort , gastroenterology , kidney
Tenofovir (TDF) is preferred nucleoside reverse transcriptase inhibitors (NRTI) for the treatment of human immunodeficiency virus infection because of its potency and safety. Renal toxicity with TDF use is low and comparable with other NRTI in clinical trials, but there are many case studies and small case series of renal dysfunction with TDF.